Digitally Enabled Quality Improvement Intervention and LDL-C Control in Atherosclerotic Cardiovascular Disease: The SAPPHIRE-LDL Cluster Randomized Clinical Trial

医学 药方 心理干预 随机对照试验 物理疗法 质量管理 干预(咨询) 星团(航天器) 审计 整群随机对照试验 内科学 门诊部 临床决策支持系统 电子处方 临床试验 梅德林 疾病 急诊医学 桥接(联网) 低密度脂蛋白胆固醇 重症监护医学 生活质量(医疗保健) 交叉研究 血管疾病
作者
Maria Julia Machline-Carrion,Karla Santo,Alysson Nathan Girotto,Priscila Raupp,Pedro Marton Pereira,Frederico Monfardini,Renato Hideo Nakagawa Santos,M de B Pereira,Bruna S. Sampaio,Diogo D F Moia,de Farias,Frederico Toledo Campo Dall’Orto,Ricardo Pavanello,Carísi Anne Polanczyk,Odílson Marcos Silvestre,Marcelo Heitor Vieira Assad,Maria Sanali Moura de Oliveira Paiva,Mayler Olombrada Nunes de Santos,Marina Politi Okoshi,Carlos Eduardo da Costa Nunes Bosso
出处
期刊:JAMA Cardiology [American Medical Association]
卷期号:11 (9): 810-810 被引量:2
标识
DOI:10.1001/jamacardio.2026.2510
摘要

Importance: Bridging the low-density lipoprotein cholesterol (LDL-C) care gap in patients with established atherosclerotic cardiovascular disease (ASCVD) is challenging. Few quality improvement (QI) interventions have successfully improved patient care. Objective: To evaluate the impact of a digitally enabled, multifaceted, QI intervention on the control of LDL-C concentration in patients with ASCVD. Design, Setting and Participants: This was a pragmatic, 2-arm, cluster randomized clinical trial. A total of 28 clusters (public or private outpatient clinics) in Brazil were randomized to receive a digitally enabled QI intervention or routine practice (control). Adult patients (≥18 years) with established ASCVD were enrolled between November 2023 and December 2024 and followed up for 6 months. Intervention: The intervention comprised a structured, digitally enabled QI strategy integrating previsit screening, electronic clinical decision support algorithms, audit and feedback mechanisms, and targeted clinician and patient engagement tools embedded within routine workflows to support lipid monitoring, treatment intensification, and adherence. Main Outcomes and Measures: The primary outcome was mean LDL-C level at 6 months. Secondary outcomes included relative LDL-C change, achievement of LDL-C targets (<50 mg/dL and ≥50% reduction; to convert to millimoles per liter, multiply by 0.0259), and prescription of lipid-lowering therapies. All analyses were performed following the intention-to-treat principle and accounted for the cluster design by using a generalized estimating equations model. Results: Among 1465 enrolled patients (mean [SD] age, 62.3 [10.1] years; 894 male [61.0%]; 714 intervention; 751 control), mean (SD) LDL-C concentration at 6 months was 76.3 (37.5) mg/dL in the intervention group and 85.6 (37.1) mg/dL in the control group. The adjusted mean difference was -6.62 mg/dL (95% CI, -11.11 to -2.13 mg/dL; P = .004). Patients in the intervention group were more likely to achieve an LDL-C concentration less than 50 mg/dL (23.5% vs 13.4%; odds ratio, 1.86; 95% CI, 1.30-2.65) and a 50% or greater reduction in LDL-C concentration (18.6% vs 13.4%; odds ratio, 1.76; 95% CI, 1.27-2.43). Prescription of intensive and combination lipid-lowering therapy was significantly higher in the intervention group. No significant differences in major cardiovascular events were observed. Conclusions and Relevance: In this pragmatic cluster randomized clinical trial, a digitally enabled, multifaceted strategy produced modest LDL-C reduction and increased treatment intensification among patients with ASCVD. However, a proportion of patients had LDL-C levels that remained above recommended LDL-C targets, underscoring that the strategy tested was only partially effective in eliminating the residual care gap. Trial Registration: ClinicalTrials.gov Identifier: NCT05622929.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Hello的应助被开心采纳,获得10
刚刚
Orange的应助被苹果丑采纳,获得30
1秒前
灝男发布了新的文献求助30
1秒前
阮大帅气完成签到,获得积分10
2秒前
2秒前
打老虎发布了新的文献求助10
2秒前
saflgf发布了新的文献求助10
2秒前
3秒前
xm完成签到,获得积分10
5秒前
涵霸天发布了新的文献求助10
6秒前
liuyi发布了新的文献求助10
6秒前
6秒前
gao完成签到,获得积分10
6秒前
脑洞疼的应助被succo采纳,获得10
7秒前
syvshc的应助被Yonnn采纳,获得10
7秒前
烟花的应助被默默灵煌采纳,获得10
7秒前
7秒前
ku发布了新的文献求助20
8秒前
完美世界的应助被三分之二采纳,获得10
8秒前
Harry发布了新的文献求助20
8秒前
自然的以亦完成签到,获得积分10
8秒前
Zyj完成签到,获得积分10
9秒前
yjswjf完成签到,获得积分10
10秒前
一笑没的应助被苏苏采纳,获得10
10秒前
卷卷完成签到,获得积分10
11秒前
13秒前
13秒前
1900发布了新的文献求助10
13秒前
mm发布了新的文献求助10
13秒前
灝男发布了新的文献求助10
13秒前
15秒前
15秒前
Ann发布了新的文献求助10
15秒前
16秒前
灝男发布了新的文献求助10
17秒前
Dong完成签到 ,获得积分10
17秒前
17秒前
17秒前
molihuakai的应助被三分之二采纳,获得10
18秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177802
求助须知:如何正确求助?哪些是违规求助? 9568632
关于积分的说明 21799933
捐赠科研通 7772424
什么是DOI,文献DOI怎么找? 3432505
关于科研通互助平台的介绍 2556698
邀请新用户注册赠送积分活动 2478055